The older prisoner health and social care assessment and plan (OHSCAP) versus treatment as usual: a randomised controlled trial.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
10 11 2021
Historique:
received: 09 09 2020
accepted: 11 10 2021
entrez: 11 11 2021
pubmed: 12 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

Older people are the fastest-growing demographic group among prisoners in England and Wales and they have complex health and social care needs. Their care is frequently ad hoc and uncoordinated. No previous research has explored how to identify and appropriately address the needs of older adults in prison. We hypothesised that the Older prisoner Health and Social Care Assessment and Plan (OHSCAP) would significantly increase the proportion of met health and social care needs 3 months after prison entry, compared to treatment as usual (TAU). The study was a parallel randomised controlled trial (RCT) recruiting male prisoners aged 50 and over from 10 prisons in northern England. Participants received the OHSCAP or TAU. A clinical trials unit used minimisation with a random element as the allocation procedure. Data analysis was conducted blind to allocation status. The intervention group had their needs assessed using the OHSCAP tool and care plans were devised; processes that lasted approximately 30 min in total per prisoner. TAU included the standard prison health assessment and care. The intention to treat principle was followed. The trial was registered with the UK Clinical Research Network Portfolio (ISRCTN ID: 11841493) and was closed on 30 November 2016. Data were collected between 28 January 2014 and 06 April 2016. Two hundred and forty nine older prisoners were assigned TAU of which 32 transferred prison; 12 were released; 2 withdrew and 1 was deemed unsafe to interview. Two hundred and fifty three 3 prisoners were assigned the OHSCAP of which 33 transferred prison; 11 were released; 6 withdrew and 1 was deemed unsafe to interview. Consequently, data from 202 participants were analysed in each of the two groups. There were no significant differences in the number of unmet needs as measured by the Camberwell Assessment of Needs - Forensic Short Version (CANFOR-S). The mean number of unmet needs for the OHSCAP group at follow-up was 2.03 (SD = 2.07) and 2.06 (SD = 2.11) for the TAU group (mean difference = 0.088; 95% CI - 0.276 to 0.449, p = 0.621). No adverse events were reported. The OHSCAP was fundamentally not implemented as planned, partly due to the national prison staffing crisis that ensued during the study period. Therefore, those receiving the OHSCAP did not experience improved outcomes compared to those who received TAU. Current Controlled Trials: ISRCTN11841493 , 25/10/2012.

Sections du résumé

BACKGROUND
Older people are the fastest-growing demographic group among prisoners in England and Wales and they have complex health and social care needs. Their care is frequently ad hoc and uncoordinated. No previous research has explored how to identify and appropriately address the needs of older adults in prison. We hypothesised that the Older prisoner Health and Social Care Assessment and Plan (OHSCAP) would significantly increase the proportion of met health and social care needs 3 months after prison entry, compared to treatment as usual (TAU).
METHODS
The study was a parallel randomised controlled trial (RCT) recruiting male prisoners aged 50 and over from 10 prisons in northern England. Participants received the OHSCAP or TAU. A clinical trials unit used minimisation with a random element as the allocation procedure. Data analysis was conducted blind to allocation status. The intervention group had their needs assessed using the OHSCAP tool and care plans were devised; processes that lasted approximately 30 min in total per prisoner. TAU included the standard prison health assessment and care. The intention to treat principle was followed. The trial was registered with the UK Clinical Research Network Portfolio (ISRCTN ID: 11841493) and was closed on 30 November 2016.
RESULTS
Data were collected between 28 January 2014 and 06 April 2016. Two hundred and forty nine older prisoners were assigned TAU of which 32 transferred prison; 12 were released; 2 withdrew and 1 was deemed unsafe to interview. Two hundred and fifty three 3 prisoners were assigned the OHSCAP of which 33 transferred prison; 11 were released; 6 withdrew and 1 was deemed unsafe to interview. Consequently, data from 202 participants were analysed in each of the two groups. There were no significant differences in the number of unmet needs as measured by the Camberwell Assessment of Needs - Forensic Short Version (CANFOR-S). The mean number of unmet needs for the OHSCAP group at follow-up was 2.03 (SD = 2.07) and 2.06 (SD = 2.11) for the TAU group (mean difference = 0.088; 95% CI - 0.276 to 0.449, p = 0.621). No adverse events were reported.
CONCLUSION
The OHSCAP was fundamentally not implemented as planned, partly due to the national prison staffing crisis that ensued during the study period. Therefore, those receiving the OHSCAP did not experience improved outcomes compared to those who received TAU.
TRIAL REGISTRATION
Current Controlled Trials: ISRCTN11841493 , 25/10/2012.

Identifiants

pubmed: 34758798
doi: 10.1186/s12889-021-11965-5
pii: 10.1186/s12889-021-11965-5
pmc: PMC8579542
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2061

Informations de copyright

© 2021. The Author(s).

Références

Br J Psychiatry. 2001 Dec;179:535-9
pubmed: 11731358
Age Ageing. 2001 Sep;30(5):403-7
pubmed: 11709379
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Age Ageing. 1996 Mar;25(2):113-20
pubmed: 8670538
Age Ageing. 2013 Sep;42(5):589-93
pubmed: 23793783
Int Psychogeriatr. 2011 Oct;23(8):1354-60
pubmed: 21489341
Int J Geriatr Psychiatry. 2012 Nov;27(11):1155-62
pubmed: 22392606
Int J Geriatr Psychiatry. 2008 Sep;23(9):957-62
pubmed: 18395886

Auteurs

Katrina Forsyth (K)

The University of Manchester, Oxford Road, Manchester, M13 9PL, UK. Katrina.Forsyth@manchester.ac.uk.

Roger T Webb (RT)

The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Laura Archer Power (LA)

Lancashire Police, Saunders Lane, Hutton, PR4 5SB, UK.

Richard Emsley (R)

King's College, London Strand, London, WC2R 2LS, UK.

Jane Senior (J)

The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Alistair Burns (A)

The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

David Challis (D)

Institute of Mental Health, Innovation Park, Triumph Road, Nottingham, NG7 2TU, UK.

Adrian Hayes (A)

Avon and Wiltshire Mental Health Partnership NHS Trust, Bath NHS House, Newbridge Hill, Bath, BA1 3QE, UK.

Rachel Meacock (R)

The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Elizabeth Walsh (E)

Care UK, Hawker House, 5-6 Napier Court, Napier Road, Reading, Berkshire, RG1 8BW, UK.

Stuart Ware (S)

Restore Support Network, Exeter CVS, Wat Tyler House, King William Street, Exeter, EX4 6PD, UK.

Jenny Shaw (J)

The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH